CT Angiography-Derived RECHARGE Score Predicts Successful Percutaneous Coronary Intervention in Patients with Chronic

Jiahui Li1, Rui Wang2, Christian Tesche3,4

  • 1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.

Insights

The non-invasive RECHARGECCTA score accurately predicts 30-minute guidewire crossing in chronic total occlusion percutaneous coronary intervention (CTO-PCI). While comparable to other scores for procedural success, it offers an improved non-invasive alternative for predicting wire crossing outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Imaging

Background:

  • Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) remains challenging.
  • Accurate pre-procedural assessment is crucial for successful CTO-PCI.
  • Existing scoring systems often rely on invasive methods.

Purpose of the Study:

  • To evaluate the accuracy of the coronary CT angiography (CCTA)-derived Registry of Crossboss and Hybrid procedures (RECHARGE) score (RECHARGECCTA) in predicting CTO-PCI success.
  • To compare the RECHARGECCTA score with the invasive RECHARGE score (RECHARGECA) and other CCTA-based scores.

Main Methods:

  • Retrospective analysis of 124 patients with 131 CTO lesions undergoing CCTA before CTO-PCI.
  • Calculation and comparison of RECHARGECCTA scores with RECHARGECA, J-CTO, CT-RECTOR, and KCCT scores.
  • Assessment of predictive performance using procedural success and 30-minute guidewire crossing as endpoints.

Main Results:

  • Procedural success rate was 72%, with 61% achieving 30-minute wire crossing.
  • RECHARGECCTA showed no significant difference from RECHARGECA for procedural success (AUC 0.718 vs. 0.757).
  • RECHARGECCTA demonstrated superior prediction for 30-minute wire crossing compared to RECHARGECA (p=0.001) and comparable performance to other CCTA scores.

Conclusions:

  • The non-invasive RECHARGECCTA score is a valuable tool for predicting 30-minute guidewire crossing in CTO-PCI.
  • It offers an accurate, non-invasive alternative to invasive assessments for this specific outcome.
  • While promising, the RECHARGECCTA score may not entirely replace existing CCTA-based scores for predicting overall procedural success.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
219
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
91
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
124